Bell's Palsy Complicated by Hypertensive Crisis: A Case Report and Review of Diagnostic and Therapeutic Challenges: Bell's Palsy Complicated by Hypertensive Crisis

Fariz Atiqi Ariewibawa; Hafidz Ramadhan Al Hasan; Habel Ryan Annerico Sianipar; Reydo Evril Nugroho; Wahyu Prasasti Mutiadesi; Peppy Nawangsasi; Tamam Jauhar; Ronald Pratama Adiwinoto

doi:10.59747/smjidisurabaya.v2i2.69

Authors

Fariz Atiqi Ariewibawa Faculty of Medicine Hang Tuah University
Hafidz Ramadhan Al Hasan Faculty of Medicine Hang Tuah University
Habel Ryan Annerico Sianipar Faculty of Medicine Hang Tuah University
Reydo Evril Nugroho Faculty of Medicine Hang Tuah University
Wahyu Prasasti Mutiadesi Department of Anatomy, Faculty of Medicine, Hang Tuah University
Peppy Nawangsasi Department of Anatomy, Faculty of Medicine, Hang Tuah University
Tamam Jauhar Department of Pharmacology, Faculty of Medicine, Hang Tuah University
Ronald Pratama Adiwinoto Department of Public Health, Faculty of Medicine Hang Tuah University https://orcid.org/0000-0002-2112-610X

DOI:

https://doi.org/10.59747/smjidisurabaya.v2i2.69

Keywords:

bell's palsy, facial palsy, hypertensive crisis, hypertension, stroke, primary health care, differential diagnoses

Abstract

Background: Bell's palsy is a neurological condition characterized by acute unilateral facial paralysis. While it is often idiopathic, it can sometimes be associated with other underlying conditions, complicating diagnosis and management. Objectives: This case report aims to present a unique case of Bell's palsy complicated by a hypertensive crisis, emphasizing the importance of differential diagnosis and careful pharmacotherapy management. Case Presentation: A 63-year-old male presented to Ngletih Community Health Center with a four-day history of right-sided facial paralysis and slurred speech, following exposure to a fan while sleeping. Physical examination revealed a hypertensive crisis with a blood pressure of 185/144 mmHg. Neurological assessment showed no signs of stroke, such as limb weakness or other lateralizing signs. Conclusion: This case underscores the importance of a comprehensive diagnostic approach and an individualized treatment plan for patients with Bell's palsy and concurrent hypertensive crisis. Awareness of such complications can aid clinicians in optimizing patient outcomes while minimizing risks.

References

Adour, K.K., Wingerd, J., Bell, D.N., Manning, J.J., Hurley, J.P., 1972. Prednisone treatment for idiophatic facial paralysis (Bell’s palsy). N. Engl. J. Med. 287, 1268–1272.

Alanazi, F., Kashoo, F.Z., Alduhishy, A., Aldaihan, M., Ahmad, F., Alanazi, A., 2022. Incidence rate, risk factors, and management of Bell’s palsy in the Qurayyat region of Saudi Arabia. PeerJ 10, 1–13. https://doi.org/10.7717/peerj.14076

Alharbi, R., Kashoo, F.Z., Ahmed, M., Alqahtani, M., Aloyuni, S., Alzhrani, M., Alanazi, A.D., Sidiq, M., Alharbi, B.H., Nambi, G., 2023. Effect of neural mobilisation in Bell’s palsy: A randomised controlled trial. Hong Kong Physiother. J. Off. Publ. Hong Kong Physiother. Assoc. Ltd. = Wu li chih liao 43, 93–103. https://doi.org/10.1142/S1013702523500063

Baugh, R.F., Basura, G.J., Ishii, L.E., Schwartz, S.R., Drumheller, C.M., Burkholder, R., Deckard, N.A., Dawson, C., Driscoll, C., Gillespie, M.B., Gurgel, R.K., Halperin, J., Khalid, A.N., Kumar, K.A., Micco, A., Munsell, D., Rosenbaum, S., Vaughan, W., 2013. Clinical Practice Guideline: Bell’s Palsy. Otolaryngol. Neck Surg. 149, S1–S27. https://doi.org/10.1177/0194599813505967

Charchar, F.J., Prestes, P.R., Mills, C., Ching, S.M., Neupane, D., Marques, F.Z., Sharman, J.E., Vogt, L., Burrell, L.M., Korostovtseva, L., Zec, M., Patil, M., Schultz, M.G., Wallen, M.P., Renna, N.F., Islam, S.M.S., Hiremath, S., Gyeltshen, T., Chia, Y.C., Gupta, A., Schutte, A.E., Klein, B., Borghi, C., Browning, C.J., Czesnikiewicz-Guzik, M., Lee, H.Y., Itoh, H., Miura, K., Brunström, M., Campbell, N.R.C., Akinnibossun, O.A., Veerabhadrappa, P., Wainford, R.D., Kruger, R., Thomas, S.A., Komori, T., Ralapanawa, U., Cornelissen, V.A., Kapil, V., Li, Y., Zhang, Y., Jafar, T.H., Khan, N., Williams, B., Stergiou, G., Tomaszewski, M., 2024. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J. Hypertens. 42, 23–49. https://doi.org/10.1097/HJH.0000000000003563

Choi, S.Y., Kim, J.M., Jung, J., Park, D.C., Yoo, M.C., Kim, S.S., Kim, S.H., Yeo, S.G., 2022. Review of Drug Therapy for Peripheral Facial Nerve Regeneration That Can Be Used in Actual Clinical Practice. Biomedicines 10, 1–34. https://doi.org/10.3390/biomedicines10071678

Cifkovâ, R., 2014. Antiplatelet and lipid-lowering drugs in hypertension. Eur. Cardiol. Rev. 9, 16–20. https://doi.org/10.15420/ecr.2014.9.1.16

Coelho, J.C., da Luz Pádua Guimarães, M.C., de Campos, C.L., Florido, C.F., da Silva, G.V., Geraldo Pierin, A.M., 2021. Blood pressure control of hypertensive patients followed in a high complexity clinic and associated variables. Brazilian J. Nephrol. 43, 207–216. https://doi.org/10.1590/2175-8239-JBN-2020-0133

Dalrymple, S.N., Row, J.H., Gazewood, J., 2023. Bell Palsy: Rapid Evidence Review. Am. Fam. Physician 107, 415–420.

De Almeida, J.R., Guyatt, G.H., Sud, S., Dorion, J., Hill, M.D., Kolber, M.R., Lea, J., Loong, S., Somogyi, B.K., Westerberg, B.D., White, C., Chen, J.M., 2014. Management of Bell palsy: Clinical practice guideline. CMAJ 186, 917–922. https://doi.org/10.1503/cmaj.131801

Demir, D., Genç, S., Güven, M., Yılmaz, M.S., Kara, A., Erkorkmaz, Ü., 2020. Intratympanic steroid treatment of bell’s palsy in patients with comorbid disease: A preliminary report. J. Int. Adv. Otol. 16, 47–52. https://doi.org/10.5152/iao.2019.5415

Dewi, N.M.R.P., Dharma, B.D.I., Silakarma, I.G.N.M.D., Samsarga, G.W., 2020. Multifaceted rehabilitation strategies for ramsay hunt syndrome: A case report and a review of literature. Bali Med. J. 9, 477–480. https://doi.org/10.15562/bmj.v9i2.1661

Ellis, S.L., Carter, B.L., Leehey, M.A., Conry, C.M., 1999. Bell’s palsy in an older patient with uncontrolled hypertension due to medication nonadherence. Ann. Pharmacother. 33, 1269–1273. https://doi.org/10.1345/aph.19129

Holland, N.J., Bernstein, J.M., Hamilton, J.W., 2012. Hyperbaric oxygen therapy for Bell’s palsy. Cochrane Database Syst. Rev. 2016. https://doi.org/10.1002/14651858.CD007288.pub2

Jackson, S.H.D., Beevers, D.G., Myers, K., 1981. Does long-term low-dose corticosteroid therapy cause hypertension? Clin. Sci. 61, 381–383. https://doi.org/10.1042/cs061381s

Jeong, J., Yoon, S.R., Lim, H., Oh, J., Choi, H.S., 2021. Risk factors for Bell’s palsy based on the Korean National Health Insurance Service National Sample Cohort data. Sci. Rep. 11, 9–14. https://doi.org/10.1038/s41598-021-02816-9

Jiang, C., Wang, J., Chong, Y., Xu, W., Liang, W., 2024. Microvascular decompression for hemifacial spasm after Bell’s palsy: a retrospective clinical study. Neurosurg. Rev. 47. https://doi.org/10.1007/S10143-024-02328-W

Jörg, R., Milani, G.P., Simonetti, G.D., Bianchetti, M.G., Simonetti, B.G., 2013. Peripheral facial nerve palsy in severe systemic hypertension: A systematic review. Am. J. Hypertens. 26, 351–356. https://doi.org/10.1093/ajh/hps045

Jung, S.Y., Jung, J., Byun, J.Y., Park, M.S., Kim, S.H., Yeo, S.G., 2018. The effect of metabolic syndrome on Bell’s palsy recovery rate. Acta Otolaryngol. 138, 670–674. https://doi.org/10.1080/00016489.2018.1425902

Lavin, P.J.M., Weissman, B.M., 1985. Bell’s palsy’ in accelerated hypertension. Postgrad. Med. 77, 165–168. https://doi.org/10.1080/00325481.1985.11699035

Liu, H., Sun, Q., Bi, W., Mu, X., Li, Y., Hu, M., 2023. Genetic association of hypertension and several other metabolic disorders with Bell’s palsy. Front. Genet. 14. https://doi.org/10.3389/FGENE.2023.1077438

Lloyd, A.V.C., Jewitt, D.E., Still, J.D.L., 1966. Facial paralysis in children with hypertension. Arch. Dis. Child. 41, 292–294. https://doi.org/10.1136/adc.41.217.292

Madhok, V.B., Gagyor, I., Daly, F., Somasundara, D., Sullivan, M., Gammie, F., Sullivan, F., 2016a. Corticosteroids for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst. Rev. 2016. https://doi.org/10.1002/14651858.CD001942.pub5

Masterson, L., Vallis, M., Quinlivan, R., Prinsley, P., 2015. Assessment and management of facial nerve palsy. BMJ 351, 1–5. https://doi.org/10.1136/bmj.h3725

Mayhew, G., Carhart, E., 2015. Differential Diagnosis: Bell’s Palsy vs. Stroke. They can look similar, but it’s important to tell them apart. EMS World 44, 47–53.

McCaul, J.A., Cascarini, L., Godden, D., Coombes, D., Brennan, P.A., Kerawala, C.J., 2014. Evidence based management of Bell’s palsy. Br. J. Oral Maxillofac. Surg. 52, 387–391. https://doi.org/10.1016/j.bjoms.2014.03.001

Mueanchoo, P., Tepparak, N., Chongphattararot, P., Pruphetkaew, N., Setthawatcharawanich, S., Korathanakhun, P., Amornpojnimman, T., Sathirapanya, C., Sathirapanya, P., 2024a. Association between Bell’s Palsy and Cardiometabolic Risks: An Age- and Sex-Matched Case–Control Study. J. Pers. Med. 14. https://doi.org/10.3390/jpm14020197

Nuraini, B., 2015. Risk factors of hypertension. J. Major. 4, 10–19.

Patel, D.K., Levin, K.H., 2015. Bell palsy: Clinical examination and management. Cleve. Clin. J. Med. 82, 419–426. https://doi.org/10.3949/CCJM.82A.14101

Prabasheela, B., Sakithya, V., Nandhini, V., Logeshwari, M., 2017. Understanding Bell’s palsy –a review. Pharm. Biol. Eval. 4, 130. https://doi.org/10.26510/2394-0859.pbe.2017.20

Prousky, J.E., 2012. Efficacy of vitamin B 3 and its related coenzymes for the treatment of Bell’s palsy, Huntington’s disease, migraine and chronic tension-type headaches, multiple sclerosis, Parkinson’s disease, and tinnitus. J. Orthomol. Med. 27, 69–86.

Riga, M., Kefalidis, G., Danielides, V., 2012. The role of diabetes mellitus in the clinical presentation and prognosis of bell palsy. J. Am. Board Fam. Med. 25, 819–826. https://doi.org/10.3122/jabfm.2012.06.120084

Romadhoni, Herianti, S.O., Yekti, M., Khamsiyati, S.I., 2024. Diabetes Mellitus and Hypertension are Associated with Bell’s Palsy. Magna Neurol. 2, 5–8. https://doi.org/10.20961/magnaneurologica.v2i1.908

Savadi-Oskouei, D., Abedi, A., Sadeghi-Bazargani, H., 2008. Independent role of hypertension in Bell’s palsy: A case-control study. Eur. Neurol. 60, 253–257. https://doi.org/10.1159/000151701

Schwartz, S.R., Jones, S.L., Getchius, T.S.D., Gronseth, G.S., 2014. Reconciling the clinical practice guidelines on Bell’s palsy from the AAO-HNSF and the AAN. Otolaryngol. - Head Neck Surg. (United States) 150, 709–711. https://doi.org/10.1177/0194599814529079

Silviana, M., Tugasworo, D., Belladonna, M., 2021. Efficacy of Vitamin B1, B6, and B12 Forte Therapy in Peripheral Neuropathy Patients. Diponegoro Int. Med. J. 2, 14–19. https://doi.org/10.14710/dimj.v2i1.9549

Vakharia, Kavita, Vakharia, Kalpesh, 2016. Bell’s Palsy. Facial Plast. Surg. Clin. North Am. 24, 1–10. https://doi.org/10.1016/J.FSC.2015.08.001

Wang, L.L., Guan, L., Hao, P.L., Du, J.L., Zhang, M.X., 2015. Acupuncture and vitamin B12 injection for bell’s palsy: No high-quality evidence exists. Neural Regen. Res. 10, 808–813. https://doi.org/10.4103/1673-5374.156987

Wang, Z., Zhang, J., Zhang, Z., Liu, Y., Ren, S., Sun, H., Meng, D., Liu, R., Zhang, Y., 2024. Effects of acupuncture for Bell’s palsy patients in the acute phase and its impact on facial nerve edema: a study protocol for a randomized, controlled trial. Front. Neurol. 15, 1327206. https://doi.org/10.3389/fneur.2024.1327206

Warner, M.J., Hutchison, J., Varacallo, M., 2023. Bell Palsy. StatPearls.

Wu, D., Lan, X., Litscher, G., Zhao, Y.L., Wu, Y.Q., Dai, R.J., Cao, K., Wang, Y., Chen, L.Q., 2024. Laser acupuncture and photobiomodulation therapy in Bell’s palsy with a duration of greater than 8 weeks: a randomized controlled trial. Lasers Med. Sci. 39. https://doi.org/10.1007/s10103-023-03970-4

Zhang, W., Xu, L., Luo, T., Wu, F., Zhao, B., Li, X., 2020. The etiology of Bell’s palsy: a review. J. Neurol. 267, 1896–1905. https://doi.org/10.1007/s00415-019-09282-4

Bell's Palsy Complicated by Hypertensive Crisis: A Case Report and Review of Diagnostic and Therapeutic Challenges